ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,674Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 166

$1.39M Total Retail Price of All Prescriptions

Rank: 6 out of 166

599 Patients Receiving at Least One Drug in Part D
18%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 1,834 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$110 was the average price of a prescription from this provider, compared to $233 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
RISPERIDONE 890 135 1 15
QUETIAPINE FUMARATE 769 175 2 21
TRAZODONE HCL 724 132 3 20
VENLAFAXINE HCL ER 552 60 4 37
FLUOXETINE HCL 546 74 5 31
BENZTROPINE MESYLATE 517 54 R 6 38
CITALOPRAM HBR 480 71 7 12
OLANZAPINE 464 57 8 35
HALOPERIDOL 443 54 9 50
DIVALPROEX SODIUM 366 42 10 9
LITHIUM CARBONATE 353 36 11 48
SERTRALINE HCL 352 46 12 17
DIVALPROEX SODIUM ER 352 11 12 8
PAROXETINE HCL 329 38 14 44
ABILIFY 326 11 15 39
BUSPIRONE HCL 310 79 16 54
SEROQUEL 285 57 17 46
GABAPENTIN 269 29 18 3
MIRTAZAPINE 266 110 19 36
CLOZAPINE 252 0 20 28
CYMBALTA 251 54 21 42
PERPHENAZINE 184 60 22 74
TOPIRAMATE 162 0 23 6
LAMOTRIGINE 159 12 24 5
NORTRIPTYLINE HCL 152 25 25 27
ZIPRASIDONE HCL 150 21 26 80
OXCARBAZEPINE 134 0 27 29
VENLAFAXINE HCL 130 23 28 83
CARBAMAZEPINE 119 13 29 13
BUPROPION HCL SR 115 34 30 57
TRIHEXYPHENIDYL HCL 113 0 R 31 68
HYDROXYZINE PAMOATE 109 0 R 32 75
AMITRIPTYLINE HCL 104 0 R 33 30
BUPROPION XL 98 0 34 63
FLUPHENAZINE HCL 90 13 35 91
ZYPREXA 84 0 36 94
ESCITALOPRAM OXALATE 82 0 37 71
TRIFLUOPERAZINE HCL 76 12 38 99
ZOLPIDEM TARTRATE 67 0 39 45
THIORIDAZINE HCL 63 0 R 40 106
FLUVOXAMINE MALEATE 58 15 41 111
NALTREXONE HCL 56 0 42 112
PROPRANOLOL HCL 56 0 42 33
THIOTHIXENE 55 0 44 116
GEODON 52 0 45 120
HALOPERIDOL DECANOATE 51 0 46 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.